CRL ▼ -0.1% - Charles River Laboratories International, Inc. $CRL - Charles River Leverages Expertise in Rapid and In Vitro Methods to Reduce Cell Banking Timelines Charles River Laboratories shares fell 0.1% today despite the company announcing it is leveraging its expertise in rapid and in vitro methods to reduce cell banking timelines. The modest decline suggests investors viewed the operational efficiency update as largely priced in or were unmoved by the development timeline improvement. 17-SEP-2026 08:03 AM ET